Nitroglycerin's mode of action in angina pectoris remains uncertain, with previous studies failing to correlate its haemodynamic effects during exercise with the prevention of pain.
Does nitroglycerin prevent pain during exercise by altering haemodynamic responses in patients with angina pectoris?
The text introduces a study aiming to correlate the haemodynamic effects of nitroglycerin during exercise with the prevention of angina pain to determine its mechanism of action.
Nitroglycerin isgenerallyagreed tobethemost effective drugavailable forthetreatment ofangina pectoris, butitsmodeofaction remains uncertain. Two mainexplanations havebeenputforwird. Thefirst suggests that itactsbylowering thearterial pressureandsoreducing cardiac work;thesecond thatitactsbydilating thecoronaryarteries andso improving themyocardial bloodsupply. Formany yearsthecoronarydilator action ofthedrughas beenwidely accepted astheprobable mechanism for itstherapeutic effect, anditsaction inreducing blood pressurehasbeenregarded asofsecondary importance, ifnotactually harmful. Attempts to demonstrate a beneficial effect on coronaryflowin patients withischaemic heartdisease, however, havemetwith no success,anditappearsthatsublingual nitroglycerin isunable toincrease themyocardial bloodsupply whenthecoronaryarteries are diseased (Gorlin etal., 1959; Bernstein etal., 1966). Thisfailure toconfirm thecoronarydilator theory hasledtorenewed interest inthepossibility that the drugactsbyreducing cardiac work,buttheevidencetosupportthisviewisinconclusive. Most studies oftheeffect ofnitroglycerin on thecirculatory responsetoexercise haveshownthat thedrug reduces arterial pressurebothinnormalsubjects and in patients withischaemic heartdisease (Eldridge etal., 1955;MullerandR0rvik, 1958; Christensson, Karlefors, and Westling, 1965; Najmi etal., 1967).Innoneofthese investigations, however, havethechanges inthecirculatory response beencorrelated withthealteration in capacity forexercise. Inconsequence,though itis generallyaccepted thatnitroglycerin doescause some attenuation ofthecirculatory responseto exercise, ithasbeenimpossible toassesstheextent
B. F. Robinson (Wed,) conducted a other in Angina pectoris. Nitroglycerin was evaluated. Nitroglycerin's mode of action in angina pectoris remains uncertain, with previous studies failing to correlate its haemodynamic effects during exercise with the prevention of pain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: